Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsutomu Inoue

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Kidney International|September 29, 2012
Is there no future for renal BOLD-MRI?Tsutomu Inoue, Eito Kozawa, Hirokazu Okada, et al.
The Journal of Biological Chemistry|December 11, 2025
PKM2 inhibitor suppresses kidney fibrogenesis by disrupting YAP-TEAD-CCN2 transcriptional signaling following ischemia-reperfusion injuryWakako Kosakai, Tsutomu Inoue, Tetsuya Sato, et al.
BMC Nephrology|June 20, 2026
Sex differences in peritoneal dialysis duration and management among Japanese patients: a nationwide registry analysisYusuke Watanabe, Koji Tomori, Tsutomu Inoue, et al.
Nihon Jinzo Gakkai Shi|December 16, 2015
[Assessment of chronic kidney disease using functional MRI]Tsutomu Inoue, Eito Kozawa, Masahiro Ishikawa, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2022
Analysis of the Function of CCN2 in Tubular Epithelium Cells with a Focus on Renal FibrogenesisHiroaki Amano, Tsutomu Inoue, Takeru Kusano, et al.
Chemical Communications (Cambridge, England)|February 24, 2005
Highly active and selective palladium catalyst for hydroesterification of styrene and vinyl acetate promoted by polymeric sulfonic acidsHirohito Ooka, Tsutomu Inoue, Shinichi Itsuno, et al.
Cardiorenal Medicine|March 26, 2023
Prognosis of Patients with Acute Kidney Injury due to Type 1 Cardiorenal Syndrome Receiving Continuous Renal Replacement TherapyYusuke Watanabe, Tsutomu Inoue, Shintaro Nakano, et al.
American Journal of Nephrology|June 13, 2009
D1-like receptor antagonist inhibits IL-17 expression and attenuates crescent formation in nephrotoxic serum nephritisHirokazu Okada, Tsutomu Inoue, Kumiko Hashimoto, et al.
Kidney International|July 10, 2014
The contribution of epithelial-mesenchymal transition to renal fibrosis differs among kidney disease modelsTsutomu Inoue, Akihiro Umezawa, Tsuneo Takenaka, et al.
Renal Failure|September 27, 2019
Glomerular solidification is associated with nephritis-related clinical parameters in IgA nephropathyTsutomu Inoue, Yankun Luo, Takeru Seto, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Kidney International|September 29, 2012
Is there no future for renal BOLD-MRI?Tsutomu Inoue, Eito Kozawa, Hirokazu Okada, et al.
The Journal of Biological Chemistry|December 11, 2025
PKM2 inhibitor suppresses kidney fibrogenesis by disrupting YAP-TEAD-CCN2 transcriptional signaling following ischemia-reperfusion injuryWakako Kosakai, Tsutomu Inoue, Tetsuya Sato, et al.
BMC Nephrology|June 20, 2026
Sex differences in peritoneal dialysis duration and management among Japanese patients: a nationwide registry analysisYusuke Watanabe, Koji Tomori, Tsutomu Inoue, et al.
Nihon Jinzo Gakkai Shi|December 16, 2015
[Assessment of chronic kidney disease using functional MRI]Tsutomu Inoue, Eito Kozawa, Masahiro Ishikawa, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2022
Analysis of the Function of CCN2 in Tubular Epithelium Cells with a Focus on Renal FibrogenesisHiroaki Amano, Tsutomu Inoue, Takeru Kusano, et al.
Chemical Communications (Cambridge, England)|February 24, 2005
Highly active and selective palladium catalyst for hydroesterification of styrene and vinyl acetate promoted by polymeric sulfonic acidsHirohito Ooka, Tsutomu Inoue, Shinichi Itsuno, et al.
Cardiorenal Medicine|March 26, 2023
Prognosis of Patients with Acute Kidney Injury due to Type 1 Cardiorenal Syndrome Receiving Continuous Renal Replacement TherapyYusuke Watanabe, Tsutomu Inoue, Shintaro Nakano, et al.
American Journal of Nephrology|June 13, 2009
D1-like receptor antagonist inhibits IL-17 expression and attenuates crescent formation in nephrotoxic serum nephritisHirokazu Okada, Tsutomu Inoue, Kumiko Hashimoto, et al.
Kidney International|July 10, 2014
The contribution of epithelial-mesenchymal transition to renal fibrosis differs among kidney disease modelsTsutomu Inoue, Akihiro Umezawa, Tsuneo Takenaka, et al.
Renal Failure|September 27, 2019
Glomerular solidification is associated with nephritis-related clinical parameters in IgA nephropathyTsutomu Inoue, Yankun Luo, Takeru Seto, et al.
Pageof 14